Skeletal muscle contributions to reduced fitness in cystic fibrosis youth

Background Increased maximal oxygen uptake (V̇O2max) is beneficial in children with cystic fibrosis (CF) but remains lower compared to healthy peers. Intrinsic metabolic deficiencies within skeletal muscle (muscle “quality”) and skeletal muscle size (muscle “quantity”) are both proposed as potential causes for the lower V̇O2max, although exact mechanisms remain unknown. This study utilises gold-standard methodologies to control for the residual effects of muscle size from V̇O2max to address this “quality” vs. “quantity” debate. Methods Fourteen children (7 CF vs. 7 age- and sex-matched controls) were recruited. Parameters of muscle size – muscle cross-sectional area (mCSA) and thigh muscle volume (TMV) were derived from magnetic resonance imaging, and V̇O2max obtained via cardiopulmonary exercise testing. Allometric scaling removed residual effects of muscle size, and independent samples t-tests and effect sizes (ES) identified differences between groups in V̇O2max, once mCSA and TMV were controlled for. Results V̇O2max was shown to be lower in the CF group, relative to controls, with large ES being identified when allometrically scaled to mCSA (ES = 1.76) and TMV (ES = 0.92). Reduced peak work rate was also identified in the CF group when allometrically controlled for mCSA (ES = 1.18) and TMV (ES = 0.45). Conclusions A lower V̇O2max was still observed in children with CF after allometrically scaling for muscle size, suggesting reduced muscle “quality” in CF (as muscle “quantity” is fully controlled for). This observation likely reflects intrinsic metabolic defects within CF skeletal muscle.

[1]  C. Williams,et al.  Exercise intolerance in cystic fibrosis-the role of CFTR modulator therapies , 2021, Journal of Cystic Fibrosis.

[2]  I. Fajac,et al.  Therapeutic Approaches for Patients with Cystic Fibrosis Not Eligible for Current CFTR Modulators , 2021, Cells.

[3]  C. Williams,et al.  Quantification of thigh muscle volume in children and adolescents using magnetic resonance imaging , 2020, European journal of sport science.

[4]  M. Beer,et al.  Size-adjusted muscle power and muscle metabolism in patients with cystic fibrosis are equal to healthy controls – a case control study , 2019, BMC Pulmonary Medicine.

[5]  N. Armstrong,et al.  Interpreting Aerobic Fitness in Youth: The Fallacy of Ratio Scaling. , 2019, Pediatric exercise science.

[6]  T. Takken,et al.  CFTR Genotype and Maximal Exercise Capacity in Cystic Fibrosis. A Cross‐Sectional Study , 2017, Annals of the American Thoracic Society.

[7]  Ryan A. Harris,et al.  Blood flow regulation and oxidative stress during submaximal cycling exercise in patients with cystic fibrosis. , 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[8]  C. Williams,et al.  Scaling the Oxygen Uptake Efficiency Slope for Body Size in Cystic Fibrosis , 2017, Medicine and science in sports and exercise.

[9]  T. Takken,et al.  CrossTalk opposing view: Skeletal muscle oxidative capacity is not altered in cystic fibrosis patients , 2017, The Journal of physiology.

[10]  K. McCully,et al.  CrossTalk proposal: Skeletal muscle oxidative capacity is altered in patients with cystic fibrosis , 2017, The Journal of physiology.

[11]  A. Batterham,et al.  Size Exponents for Scaling Maximal Oxygen Uptake in Over 6500 Humans: A Systematic Review and Meta-Analysis , 2017, Sports Medicine.

[12]  C. Williams,et al.  Impaired Pulmonary V˙O2 Kinetics in Cystic Fibrosis Depend on Exercise Intensity. , 2016, Medicine and science in sports and exercise.

[13]  C. Williams,et al.  Impaired aerobic function in patients with cystic fibrosis during ramp exercise. , 2014, Medicine and science in sports and exercise.

[14]  T. Takken,et al.  Ventilatory response to exercise in adolescents with cystic fibrosis and mild-to-moderate airway obstruction , 2014, SpringerPlus.

[15]  C. Williams,et al.  A protocol to determine valid V˙O2max in young cystic fibrosis patients. , 2013, Journal of science and medicine in sport.

[16]  F. Sera,et al.  Quality Control Methods in Accelerometer Data Processing: Defining Minimum Wear Time , 2013, PloS one.

[17]  Gaynor Parfitt,et al.  Calibration of the GENEA accelerometer for assessment of physical activity intensity in children. , 2013, Journal of science and medicine in sport.

[18]  T. Santa-Coloma,et al.  The Mitochondrial Complex I Activity Is Reduced in Cells with Impaired Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Function , 2012, PloS one.

[19]  S. Stanojevic,et al.  Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations , 2012, European Respiratory Journal.

[20]  C. Williams,et al.  Exercise metabolism during moderate-intensity exercise in children with cystic fibrosis following heavy-intensity exercise. , 2011, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[21]  C. Ackerley,et al.  Cystic fibrosis transmembrane conductance regulator in human muscle: Dysfunction causes abnormal metabolic recovery in exercise , 2010, Annals of neurology.

[22]  C. Willíams,et al.  Establishing maximal oxygen uptake in young people during a ramp cycle test to exhaustion , 2009, British Journal of Sports Medicine.

[23]  D. Radzioch,et al.  Lack of CFTR in Skeletal Muscle Predisposes to Muscle Wasting and Diaphragm Muscle Pump Failure in Cystic Fibrosis Mice , 2009, PLoS genetics.

[24]  M. Narici,et al.  Scaling of maximal oxygen uptake by lower leg muscle volume in boys and men. , 2006, Journal of applied physiology.

[25]  A. Almudevar,et al.  Peak oxygen uptake and mortality in children with cystic fibrosis , 2004, Thorax.

[26]  R. Ross,et al.  ATS/ACCP statement on cardiopulmonary exercise testing. , 2003, American journal of respiratory and critical care medicine.

[27]  G. Beunen,et al.  An assessment of maturity from anthropometric measurements. , 2002, Medicine and science in sports and exercise.

[28]  D. Cooper,et al.  Muscle size and cardiorespiratory response to exercise in cystic fibrosis. , 2000, American journal of respiratory and critical care medicine.

[29]  L. Lands,et al.  Analysis of factors limiting maximal exercise performance in cystic fibrosis. , 1992, Clinical science.

[30]  Jacob Cohen,et al.  A power primer. , 1992, Psychological bulletin.

[31]  B. Whipp,et al.  A new method for detecting anaerobic threshold by gas exchange. , 1986, Journal of applied physiology.

[32]  N. M. Morris,et al.  Validation of a self-administered instrument to assess stage of adolescent development , 1980, Journal of youth and adolescence.

[33]  B. Wuyam,et al.  Absence of calf muscle metabolism alterations in active cystic fibrosis adults with mild to moderate lung disease. , 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[34]  T. Takken,et al.  Pediatric norms for cardiopulmonary exercise testing: In relation to sex and age , 2014 .

[35]  J. Hankinson,et al.  MULTI-ETHNIC REFERENCE VALUES FOR SPIROMETRY FOR THE 3–95 YEAR AGE RANGE: THE GLOBAL LUNG FUNCTION , 2013 .

[36]  A. Coates,et al.  Skeletal Muscle Metabolism in Cystic Fibrosis and Primary Ciliary Dyskinesia , 2011, Pediatric Research.

[37]  B. Kirby,et al.  Exercise performance and magnetic resonance imaging-determined thigh muscle volume in children , 1997, European Journal of Applied Physiology and Occupational Physiology.